• Choom™ (CHOO) has completed a non-brokered private placement for gross proceeds of C$1.95 million through the issuance of an aggregate 27,857,143 units at a price of $0.07 per unit
  • Each unit consists of one common share and one-half of one non-transferrable warrant
  • Each warrant entitles the holder to purchase an additional common share at an exercise price of $0.12 per share until February 3, 2023
  • In connection with the offering, the company has paid aggregate finders’ fees of $82,120 in cash and issued 1,173,140 finders warrants
  • Choom Holdings Inc. is up 15.12 per cent to C$0.089 per share

Choom™ (CHOO) has completed a non-brokered private placement for gross proceeds of C$1.95 million through the issuance of an aggregate 27,857,143 units at a price of $0.07 per unit.

Each unit consists of one common share and one-half of one non-transferrable warrant. Each warrant entitles the holder to purchase an additional common share at an exercise price of $0.12 per share until February 3, 2023.

In connection with the offering, the company has paid aggregate finders’ fees of $82,120 in cash and issued 1,173,140 finders warrants.

Each finder warrant entitles the holder to acquire one additional common share at a price of $0.12 per share on the same terms as the warrants until February 3, 2023.

All securities issued are subject to a hold period expiring June 4, 2021. The company intends to use the net proceeds from the private placement for general working capital and corporate purposes.

Additionally, the company advises the grant of 1,000,000 stock options to an officer. The options have an exercise price of $0.10 per share, are exercisable until February 4, 2026 and will be governed in accordance with the terms of the company’s stock option plan.

Choom™ is a fast-expanding retail cannabis company that has established one of the largest store networks in Canada.

Choom Holdings Inc. is up 15.12 per cent to C$0.089 per share.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.